Top Page
Vimian Group AB
(Frankfurt:VIMIAN)
Vimian Group AB (VIMIAN) vs. iShares MSCI Sweden ETF (EWD)
Vimian Group AB Business Overview & Revenue Model
Vimian Group AB Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 404.35M | 374.80M | 331.73M | 281.31M | 173.35M | 137.75M |
| Gross Profit | 277.82M | 258.30M | 229.43M | 193.99M | 122.85M | 95.52M |
| EBITDA | 87.72M | 82.80M | 69.19M | 66.32M | 40.98M | 65.16M |
| Net Income | 22.67M | 18.50M | 9.84M | -7.20M | 6.59M | 52.79M |
Balance Sheet | ||||||
| Total Assets | 1.14B | 1.11B | 973.68M | 923.56M | 640.72M | 456.29M |
| Cash, Cash Equivalents and Short-Term Investments | 67.50M | 64.80M | 37.50M | 42.19M | 55.11M | 29.66M |
| Total Debt | 294.00M | 233.60M | 313.80M | 220.96M | 180.37M | 85.91M |
| Total Liabilities | 444.80M | 403.30M | 446.97M | 442.06M | 282.08M | 182.05M |
| Stockholders Equity | 682.90M | 699.90M | 526.37M | 481.81M | 357.41M | 224.02M |
Cash Flow | ||||||
| Free Cash Flow | 67.15M | 43.90M | -43.48M | 15.01M | 4.52M | -793.00K |
| Operating Cash Flow | 80.38M | 58.10M | -28.58M | 25.31M | 16.01M | 4.80M |
| Investing Cash Flow | -148.90M | -76.00M | -77.68M | -188.53M | -115.00M | -105.24M |
| Financing Cash Flow | 97.10M | 44.80M | 100.55M | 150.23M | 123.94M | 118.57M |
Vimian Group AB Technical Analysis
Vimian Group AB Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | kr20.98B | 140.49 | 20.14% | ― | 44.52% | -49.29% | |
66 Neutral | $19.98B | 59.23 | 6.27% | 0.45% | 4.56% | 185.59% | |
57 Neutral | kr16.57B | 66.45 | 3.34% | ― | 15.07% | 117.65% | |
55 Neutral | kr17.90B | 75.54 | 2.43% | 5.13% | -0.57% | -81.80% | |
54 Neutral | kr18.31B | 40.24 | 3.46% | 0.81% | 0.14% | ― | |
51 Neutral | $7.37B | 0.24 | -62.86% | 2.36% | 15.01% | -2.64% | |
35 Underperform | €35.45M | ― | -181.36% | ― | -85.32% | 92.64% |
Vimian Group AB Corporate Events
Vimian Group AB announced an increase in the number of shares and votes due to the exercise of warrants and conversion of class C shares into ordinary shares. This change reflects the company’s strategic financial adjustments and may impact its market positioning by enhancing shareholder value and voting power distribution.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB announced the immediate resignation of CEO Patrik Eriksson, with CFO Carl-Johan Zetterberg Boudrie stepping in as interim CEO. The company is initiating a search for a new CEO to drive its strategic focus on profitable growth and leveraging its global scale. The changes are part of Vimian’s efforts to strengthen its leadership and continue its growth trajectory in the animal health industry.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB has announced the release of its Interim Report for the second quarter of 2025, scheduled for publication on July 18. The company will host an audiocast for investors, analysts, and media, where CEO Patrik Eriksson and CFO Carl-Johan Zetterberg Boudrie will present and discuss the report. This event underscores Vimian’s commitment to transparency and engagement with stakeholders, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB announced an increase in its number of shares and votes following the exercise of warrants from a program approved in 2022. This change reflects the addition of 2,724,260 ordinary shares, bringing the total to 526,615,332 shares, with a corresponding increase in voting rights. This development may enhance Vimian’s market position by potentially increasing its capital base and shareholder engagement.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB has initiated the subscription period for its 2022-2025 incentive program, allowing employees to subscribe to shares through a warrant program. To support this, some warrant holders have sold shares, and Vimian’s major shareholder, Fidelio Vet Holding AB, facilitated the process by lending shares to the investment bank handling the transaction. This strategic move aims to enhance liquidity and ensure a smooth subscription process for both local and foreign warrant holders, maintaining Fidelio’s shareholding position.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB has announced the acquisition of AllAccem Inc., a leading provider of veterinary dental sealant products in the US, as part of its strategy to enhance its veterinary dental offerings. This acquisition, which will integrate AllAccem into Vimian’s MedTech segment, is expected to bolster Vimian’s position in the fast-growing niche of animal dental health, leveraging AllAccem’s high-margin products and strong market presence to improve global animal dental care.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB held an Extraordinary General Meeting on June 11, 2025, where shareholders approved several key resolutions. These included adopting new Articles of Association to introduce reclassifiable and redeemable share classes for the company’s incentive program, implementing a long-term performance-based share program for employees and consultants, and updating remuneration guidelines to allow for incentive programs to be adopted by both Annual and Extraordinary General Meetings. These changes are expected to enhance Vimian’s operational flexibility and align with local laws and practices, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB has successfully issued EUR 150 million in senior unsecured bonds, significantly oversubscribed, with plans to list them on Nasdaq Stockholm. This move reflects strong investor confidence and is expected to enhance Vimian’s financial flexibility, supporting its growth in the animal health sector.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
Vimian Group AB is considering issuing a senior unsecured bond to raise EUR 125 million, with a potential framework of EUR 250 million, subject to market conditions. The proceeds will be used to refinance existing debt and support corporate activities, including acquisitions and investments, potentially impacting its financial strategy and market positioning.